Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03577379 · ClinicalTrials.gov registry record · NA

Vascular Changes of Rotator Cuff Repair Augmented With a Whole Blood Fibrin Clot

A NA study of Rotator Cuff Tear, sponsored by Santa Barbara Cottage Hospital.

Completed
Registry status
NA
Development phase
53
Enrollment target
1
Study location

NCT03577379 is a NA study of Rotator Cuff Tear that has completed, run by Santa Barbara Cottage Hospital. The registered enrollment target is 53 participants, below the 89-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03577379, a NA study of Rotator Cuff Tear, has completed, sponsored by Santa Barbara Cottage Hospital.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to assess whether undergoing surgical repair of the rotator cuff with the additional intervention of whole blood fibrin clot will improve rotator cuff vascularization at the bone-tendon interface repair site and patient outcomes compared to those who do not receive the whole blood fibrin clot intervention.

Conditions Studied

Interventions

  • OTHER Whole Blood Fibrin Clot

Study Locations (1)

California

  • De La Vina Surgery Center - Santa Barbara

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2019-03-01
Est. Completion 2022-04-25
Phase NA

Sponsor

Santa Barbara Cottage Hospital

4 total trials

What the Registry Record Tells You About NCT03577379

The ClinicalTrials.gov registry entry for NCT03577379 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 89-participant average among 11 other Rotator Cuff Tear trials with a reported enrollment target (40% lower). The listed sponsor is Santa Barbara Cottage Hospital, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rotator Cuff Tear appearing as the primary indexed condition, and to 1 intervention - of which Whole Blood Fibrin Clot is the first listed.

NCT03577379 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03577379 about?

NCT03577379 is a clinical study titled "Vascular Changes of Rotator Cuff Repair Augmented With a Whole Blood Fibrin Clot". The goal of this study is to assess whether undergoing surgical repair of the rotator cuff with the additional intervention of whole blood fibrin clot will improve rotator cuff vascularization at the bone-tendon interface repair site and patient outcomes compared to those who do not receive the whol...

What is the current status of trial NCT03577379?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2019-03-01. Estimated completion is 2022-04-25.

What conditions does trial NCT03577379 study?

This clinical trial studies the following conditions: Rotator Cuff Tear.

What interventions are being tested in trial NCT03577379?

The interventions under investigation include: Whole Blood Fibrin Clot (OTHER).

Who is sponsoring clinical trial NCT03577379?

This trial is sponsored by Santa Barbara Cottage Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03577379 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rotator Cuff Tear

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.